Ali Afnan: Process Validation: Can We Now Get Back to Basics?

FDA’s new guidance on process validation gets back to the original language of the GMPs on the subjects of control and sampling, Ali Afnan writes. After all, FDA never intended for three consecutive batches to satisfy either the spirit or the letter of the law.

By Ali Afnan, Principal, Stepchange Pharma

Share Print Related RSS
If you are not automatically redirected, follow this link:

Share Print Reprints Permissions

What are your comments?

Join the discussion today. Login Here.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments